Bezafibrate d4
| Product Name | Bezafibrate d4 |
|---|---|
| Alternate Names | Bezafibrate Stable Isotopes, Stable Isotopes of Bezafibrate |
| CAT No. | CS-O-14198 |
| CAS No. | 1189452-53-6 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 365.84 g/mol |
| Mol. For. | C₁₉H₁₆D₄ClNO₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Bezafibrate |
| Purity | 95% |
| Smileys | [2H]C1=C(C(=C(C(=C1C(=O)NCCC2=CC=C(C=C2)OC(C)(C)C(=O)O)[2H])[2H])Cl)[2H] |
| Canonical Smiles | CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl |
| InchIKey | IIBYAHWJQTYFKB-KDWZCNHSSA-N |
| Inchl | InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)/i5D,6D,7D,8D |
| IUPAC | 2-[4-[2-[(4-chloro-2,3,5,6-tetradeuteriobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Bezafibrate d4 is a deuterated form of the drug Bezafibrate, which is used to treat high cholesterol and triglyceride levels in the blood. Bezafibrate d4 is a selective agonist of peroxisome proliferator-activated receptors (PPARs), which are nuclear receptors that play a crucial role in regulating lipid and glucose metabolism. Bezafibrate d4 activates PPARs in the liver and adipose tissue, leading to an increase in the breakdown of fatty acids and the reduction of their synthesis.
Bezafibrate d4 has been extensively studied for its pharmacological properties and chemical characteristics. It has a molecular weight of 360.43 g/mol and a chemical formula of C16D4H13ClO3S. The deuterium substitution on the drug molecule provides a unique tool for studying its metabolic pathways and drug interactions.
The usage of Bezafibrate d4 is mainly in research and development of new drugs. It is used to evaluate the pharmacokinetics and pharmacodynamics of Bezafibrate and its metabolites in vitro and in vivo. The deuterated drug can also be used to study drug-drug interactions, bioavailability, and metabolism in different animal models and human subjects.
In conclusion, Bezafibrate d4 is a valuable tool for researchers in the pharmaceutical industry, who are working towards developing new drugs for the treatment of metabolic disorders such as hyperlipidemia and diabetes. The deuterated form of Bezafibrate provides a unique opportunity to study the drug's metabolic pathways and drug interactions, which can lead to the development of safer and more effective drugs.
Get an Instant Quote
Related Compounds
Bezafibrate 13C6 | Bezafibrate D6 |